U.S.-based Carlyle Group Inc (CG.O) has agreed to buy a 20 percent stake in India's Piramal Enterprises Ltd's (PIRA.NS) pharmaceutical businesses for about $490 million, the companies said in a statement on Saturday.
The capital increase aims to accelerate Piramal Pharma's organic and inorganic growth plans, according to the statement.
